Oncologists’ Perceptions and Utilization of US Therapeutic Oncology Biosimilars
Biosimilar use in clinical practice is determined by oncologists’ perceptions of and willingness to prescribe them. The authors investigated US oncologists’ perceptions and use of biosimilars.